Autoimmune hepatitis following transition from prednisolone to thrombopoietin receptor agonist therapy in immune thrombocytopenic purpura: A clinical precaution.
Saved in:
| Title: | Autoimmune hepatitis following transition from prednisolone to thrombopoietin receptor agonist therapy in immune thrombocytopenic purpura: A clinical precaution. |
|---|---|
| Authors: | Inarimori, Kaname1 (AUTHOR), Kakisaka, Keisuke1 (AUTHOR) keikaki@iwate-med.ac.jp, Watanabe, Takuya1 (AUTHOR), Sasaki, Tokio1 (AUTHOR), Fujiwara, Yudai1 (AUTHOR), Abe, Tamami1 (AUTHOR), Suzuki, Akiko1 (AUTHOR), Endo, Kei1 (AUTHOR), Yoshida, Yuichi1 (AUTHOR), Miyasaka, Akio1 (AUTHOR), Kuroda, Hidekatsu1 (AUTHOR), Matsumoto, Takayuki1 (AUTHOR) |
| Source: | Hepatology Research. Jul2025, Vol. 55 Issue 7, p1093-1097. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 13866346 |
|---|---|
| DOI: | 10.1111/hepr.14198 |
